Europe Cardiac Marker Testing Market Size, Share & Industry Trends Analysis Report By Disease, By End User, By Product (Reagents & Kits and Instruments), By Biomarker Type, By Country and Growth Forecast, 2022 - 2028

The Europe Cardiac Marker Testing Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028).

Cardiac biomarkers assist medical professionals in determining whether a heart attack (myocardial infarction), angina, heart failure, or another issue is to blame for a patient's symptoms. Increases in cardiac enzymes might potentially be a sign of myocardial ischemia or acute coronary syndrome (ACS). These conditions are treated in various ways. Making sure one receive the right care depends on a precise diagnosis.

Cardiac markers include enzymes, hormones, and proteins. They are utilized in patients for diagnosis and risk stratification in relation to chest discomfort and suspected acute coronary syndrome. They measure blood pressure and heart rate. The cardiology industry predicted to develop at the highest rate is the cardiac marker testing market, which offers excellent specificity and can aid in the detection of disorders in the early stages of presentation such as troponins.

The countries in this region have some of the best healthcare facilities in the world. According to the International Trade Administration, Germany has a very developed and powerful market for medical supplies. Carl Zeiss, Siemens, and Dragerwerk are among the companies with a long history of manufacturing high-quality medical equipment, with an emphasis on diagnostic imaging, precise medical tools, and optical technology.

The Germany market dominated the Europe Cardiac Marker Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $530.4 million by 2028.The UK market is estimated to grow a CAGR of 7.2% during (2022 - 2028). Additionally, The France market would experience a CAGR of 8.9% during (2022 - 2028).

Based on Disease, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Acute Coronary Syndrome and Ischemia. Based on End User, the market is segmented into Laboratory Testing Facilities, Point-of-Care Testing Facilities and Academic Institutions. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Biomarker Type, the market is segmented into Troponin I & T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Cardiac Marker Testing Market will Hit $8.1 Billion by 2028, at a CAGR of 8.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.

Scope of the Study

Market Segments Covered in the Report:

By Disease

• Myocardial Infarction
• Congestive Heart Failure
• Atherosclerosis
• Acute Coronary Syndrome
• Ischemia

By End User

• Laboratory Testing Facilities
• Point-of-Care Testing Facilities
• Academic Institutions

By Product

• Reagents & Kits
• Instruments

By Biomarker Type

• Troponin I & T
• Creatine kinase-MB(CK-MB)
• Natriuretic peptide (Bnp Or Nt-Probnp)
• Myoglobin
• High-sensitivity C-reactive protein(hs-CRP)
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG (Siemens AG)
• PerkinElmer, Inc.
• BioMérieux S.A.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• DiaSorin S.p.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cardiac Marker Testing Market, by Disease
1.4.2 Europe Cardiac Marker Testing Market, by End User
1.4.3 Europe Cardiac Marker Testing Market, by Product
1.4.4 Europe Cardiac Marker Testing Market, by Biomarker Type
1.4.5 Europe Cardiac Marker Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trails & Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Europe Cardiac Marker Testing Market by Disease
4.1 Europe Myocardial Infarction Market by Country
4.2 Europe Congestive Heart Failure Market by Country
4.3 Europe Atherosclerosis Market by Country
4.4 Europe Acute Coronary Syndrome Market by Country
4.5 Europe Ischemia Market by Country

Chapter 5. Europe Cardiac Marker Testing Market by End User
5.1 Europe Laboratory Testing Facilities Market by Country
5.2 Europe Point-of-Care Testing Facilities Market by Country
5.3 Europe Academic Institutions Market by Country
Chapter 6. Europe Cardiac Marker Testing Market by Product
6.1 Europe Reagents & Kits Market by Country
6.2 Europe Instruments Market by Country

Chapter 7. Europe Cardiac Marker Testing Market by Biomarker Type
7.1 Europe Troponin I & T Market by Country
7.2 Europe Creatine kinase-MB(CK-MB) Market by Country
7.3 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
7.4 Europe Myoglobin Market by Country
7.5 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country
7.6 Europe Others Market by Country

Chapter 8. Europe Cardiac Marker Testing Market by Country
8.1 Germany Cardiac Marker Testing Market
8.1.1 Germany Cardiac Marker Testing Market by Disease
8.1.2 Germany Cardiac Marker Testing Market by End User
8.1.3 Germany Cardiac Marker Testing Market by Product
8.1.4 Germany Cardiac Marker Testing Market by Biomarker Type
8.2 UK Cardiac Marker Testing Market
8.2.1 UK Cardiac Marker Testing Market by Disease
8.2.2 UK Cardiac Marker Testing Market by End User
8.2.3 UK Cardiac Marker Testing Market by Product
8.2.4 UK Cardiac Marker Testing Market by Biomarker Type
8.3 France Cardiac Marker Testing Market
8.3.1 France Cardiac Marker Testing Market by Disease
8.3.2 France Cardiac Marker Testing Market by End User
8.3.3 France Cardiac Marker Testing Market by Product
8.3.4 France Cardiac Marker Testing Market by Biomarker Type
8.4 Russia Cardiac Marker Testing Market
8.4.1 Russia Cardiac Marker Testing Market by Disease
8.4.2 Russia Cardiac Marker Testing Market by End User
8.4.3 Russia Cardiac Marker Testing Market by Product
8.4.4 Russia Cardiac Marker Testing Market by Biomarker Type
8.5 Spain Cardiac Marker Testing Market
8.5.1 Spain Cardiac Marker Testing Market by Disease
8.5.2 Spain Cardiac Marker Testing Market by End User
8.5.3 Spain Cardiac Marker Testing Market by Product
8.5.4 Spain Cardiac Marker Testing Market by Biomarker Type
8.6 Italy Cardiac Marker Testing Market
8.6.1 Italy Cardiac Marker Testing Market by Disease
8.6.2 Italy Cardiac Marker Testing Market by End User
8.6.3 Italy Cardiac Marker Testing Market by Product
8.6.4 Italy Cardiac Marker Testing Market by Biomarker Type
8.7 Rest of Europe Cardiac Marker Testing Market
8.7.1 Rest of Europe Cardiac Marker Testing Market by Disease
8.7.2 Rest of Europe Cardiac Marker Testing Market by End User
8.7.3 Rest of Europe Cardiac Marker Testing Market by Product
8.7.4 Rest of Europe Cardiac Marker Testing Market by Biomarker Type

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Approvals and Trials:
9.1.6 SWOT Analysis
9.2 Siemens Healthineers AG (Siemens AG)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 DiaSorin S.p.A.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.9 PerkinElmer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Product Launches and Product Expansions:
9.10. BioMérieux S.A.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:

TABLE 1 Europe Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 2 Europe Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cardiac Marker Testing Market
TABLE 4 Product Launches And Product Expansions– Cardiac Marker Testing Market
TABLE 5 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 6 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 7 Europe Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 8 Europe Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 9 Europe Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 Europe Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 Europe Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 28 Europe Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 29 Europe Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Instruments Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Instruments Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 34 Europe Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 35 Europe Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 47 Europe Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 48 Europe Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 49 Germany Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 50 Germany Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 51 Germany Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 52 Germany Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 53 Germany Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 Germany Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 Germany Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 56 Germany Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 57 Germany Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 58 Germany Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 59 UK Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 60 UK Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 61 UK Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 62 UK Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 63 UK Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 64 UK Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 65 UK Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 66 UK Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 67 UK Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 68 UK Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 69 France Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 70 France Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 71 France Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 72 France Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 73 France Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 74 France Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 75 France Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 76 France Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 77 France Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 78 France Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 79 Russia Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 80 Russia Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 81 Russia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 82 Russia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 83 Russia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 84 Russia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 85 Russia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 86 Russia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 87 Russia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 88 Russia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 89 Spain Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 90 Spain Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 91 Spain Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 92 Spain Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 93 Spain Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 94 Spain Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 95 Spain Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 96 Spain Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 97 Spain Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 98 Spain Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 99 Italy Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 100 Italy Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 101 Italy Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 102 Italy Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 103 Italy Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 104 Italy Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 105 Italy Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 106 Italy Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 107 Italy Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 108 Italy Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 109 Rest of Europe Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 110 Rest of Europe Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 111 Rest of Europe Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 112 Rest of Europe Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 113 Rest of Europe Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 114 Rest of Europe Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 115 Rest of Europe Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 116 Rest of Europe Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 117 Rest of Europe Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 118 Rest of Europe Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 119 Key Information – Abbott Laboratories
TABLE 120 Key Information – Siemens Healthineers AG
TABLE 121 Key information – Becton, Dickinson and Company
TABLE 122 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 123 Key Information – Thermo Fisher Scientific, Inc.
TABLE 124 Key Information – Bio-Rad Laboratories, Inc.
TABLE 125 Key Information – Danaher Corporation
TABLE 126 Key Information – DiaSorin S.p.A.
TABLE 127 key Information – PerkinElmer, Inc.
TABLE 128 Key information – BioMérieux S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Abbott Laboratories
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Siemens Healthineers AG
FIG 7 Swot analysis: Siemens AG
FIG 8 Recent strategies and developments: Thermo Fisher Scientific, Inc.